Back to Search
THOMAS MARBURY, M.D.
M.D.
Nephrology Physician
NPI: 1689734311Individual
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
ME27544(FL)
Research & Publications (20)
Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.
PMID 19608812·Anesth Analg·2009
2-rct
Pharmacokinetics of dalbavancin in patients with renal or hepatic impairment.
PMID 19318696·J Clin Pharmacol·2009
3-trial
A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
PMID 18484560·Exp Clin Endocrinol Diabetes·2008
4-observational
Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel.
PMID 12673669·Biopharm Drug Dispos·2003
3-trial
Pharmacokinetics and safety of a single oral dose of once-daily alfuzosin, 10 mg, in male subjects with mild to severe renal impairment.
PMID 12463725·J Clin Pharmacol·2002
3-trial
Pharmacokinetics of repaglinide in subjects with renal impairment.
PMID 10668848·Clin Pharmacol Ther·2000
3-trial
Effect of rifampin, a potent inducer of drug-metabolizing enzymes, on the pharmacokinetics of raltegravir.
PMID 19433563·Antimicrob Agents Chemother·2009
3-trial
Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects.
PMID 18444883·J Infect Dis·2008
3-trial
Raltegravir thorough QT/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF interval.
PMID 18441333·J Clin Pharmacol·2008
4-observational
Pharmacokinetics of telbivudine in subjects with various degrees of renal impairment.
PMID 17875994·Antimicrob Agents Chemother·2007
3-trial
Multiple-dose pharmacokinetics of peginterferon alfa-2b in patients with renal insufficiency.
PMID 17555463·Br J Clin Pharmacol·2007
3-trial
Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor.
PMID 17468348·Diabetes Care·2007
8-other
Garenoxacin pharmacokinetics in subjects with renal impairment.
PMID 17355746·Curr Med Res Opin·2007
3-trial
Pharmacokinetics of maribavir, a novel oral anticytomegalovirus agent, in subjects with varying degrees of renal impairment.
PMID 17244772·J Clin Pharmacol·2007
2-rct
Use of 24-h ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate.
PMID 16702822·Blood Press Monit·2006
2-rct
Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment.
PMID 16641441·Antimicrob Agents Chemother·2006
3-trial
Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction.
PMID 16172179·J Clin Pharmacol·2005
3-trial
Effect of impaired renal function and haemodialysis on the pharmacokinetics of aprepitant.
PMID 15910011·Clin Pharmacokinet·2005
8-other
The effect of ketoconazole on the pharmacokinetics of a selective alpha 1A-adrenoceptor antagonist.
PMID 15901753·J Clin Pharmacol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5055 S ORANGE AVE
ORLANDO, FL 32809 - Phone
- (407) 472-0227
Quick Facts
- NPI
- 1689734311
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile